Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated with Anifrolumab in the Early Access Programs - ERYTHRO

Study identifier:D3461R00058

ClinicalTrials.gov identifier:NCT06046534

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

ERYTHRO Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated with Anifrolumab in the Early Access Programs

Medical condition

Systemic Lupus Erythematosus

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

40

Study type

Observational

Age

18 Years - 130 Years

Date

Study Start Date: 27 Oct 2023
Estimated Primary Completion Date: 15 May 2024
Estimated Study Completion Date: 15 May 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Apr 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

CernerEnviza

Inclusion and exclusion criteria